- Posted in Resource Library

2023 FUTURES: New Science Sessions

A session that highlights novel and pre-clinical research in Duchenne.

Dave Anderson, PhD

Chief Scientific Officer CodeBio

See more from same speaker

Ranjan Batra, PhD

Senior Vice President, Research & Development Locanabio

See more from same speaker

Stan Froehner, PhD

Founder and Chairman Myosana Therapeutics

See more from same speaker

Peixin Zhu, PhD

VP of R&D Tevard Biosciences

See more from same speaker

Video
Share this:
Beginning the Journey - diagnosed 0-3 yearsGrowth and Transformation - diagnosed 3-6 yearsSpreading Wisdom - diagnosed 6+ years

Related Resources

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate